1237 related articles for article (PubMed ID: 16684817)
1. Mesenchymal stem cells reside in virtually all post-natal organs and tissues.
da Silva Meirelles L; Chagastelles PC; Nardi NB
J Cell Sci; 2006 Jun; 119(Pt 11):2204-13. PubMed ID: 16684817
[TBL] [Abstract][Full Text] [Related]
2. Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall.
Hegyi B; Sági B; Kovács J; Kiss J; Urbán VS; Mészáros G; Monostori E; Uher F
Int Immunol; 2010 Jul; 22(7):551-9. PubMed ID: 20497958
[TBL] [Abstract][Full Text] [Related]
3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
4. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus.
Krampera M; Marconi S; Pasini A; Galiè M; Rigotti G; Mosna F; Tinelli M; Lovato L; Anghileri E; Andreini A; Pizzolo G; Sbarbati A; Bonetti B
Bone; 2007 Feb; 40(2):382-90. PubMed ID: 17049329
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
Gnecchi M; Melo LG
Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources.
Bernardo ME; Emons JA; Karperien M; Nauta AJ; Willemze R; Roelofs H; Romeo S; Marchini A; Rappold GA; Vukicevic S; Locatelli F; Fibbe WE
Connect Tissue Res; 2007; 48(3):132-40. PubMed ID: 17522996
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.
in 't Anker PS; Noort WA; Scherjon SA; Kleijburg-van der Keur C; Kruisselbrink AB; van Bezooijen RL; Beekhuizen W; Willemze R; Kanhai HH; Fibbe WE
Haematologica; 2003 Aug; 88(8):845-52. PubMed ID: 12935972
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
Beyer Nardi N; da Silva Meirelles L
Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
10. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
Chen MY; Lie PC; Li ZL; Wei X
Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
12. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs).
Wan C; He Q; McCaigue M; Marsh D; Li G
J Orthop Res; 2006 Jan; 24(1):21-8. PubMed ID: 16419965
[TBL] [Abstract][Full Text] [Related]
13. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
[TBL] [Abstract][Full Text] [Related]
14. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.
Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X
Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478
[TBL] [Abstract][Full Text] [Related]
15. Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells.
Wang Z; Song J; Taichman RS; Krebsbach PH
Stem Cells; 2006 Jun; 24(6):1573-82. PubMed ID: 16769762
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
Zhang ZL; Tong J; Lu RN; Scutt AM; Goltzman D; Miao DS
Bone Marrow Transplant; 2009 Jan; 43(1):69-81. PubMed ID: 18711348
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
18. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
Conrad C; Niess H; Huss R; Huber S; von Luettichau I; Nelson PJ; Ott HC; Jauch KW; Bruns CJ
Circulation; 2009 Jan; 119(2):281-9. PubMed ID: 19118255
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells.
McCarty RC; Gronthos S; Zannettino AC; Foster BK; Xian CJ
J Cell Physiol; 2009 May; 219(2):324-33. PubMed ID: 19115243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]